- 081MarketSource · Medical Device Network
THINK Surgical nets up to $65m with Symbiotic Capital debt facility
Think Surgical secured a debt facility of up to $65 million from Symbiotic Capital. The company's flagship product is TMINI, a handheld robotic system for total knee arthroplasty procedures. The financing will support the company's operations and growth.
- 082MarketSource · Medical Device Network
Neuraptive secures exclusive licence from Washington University for nerve device
Neuraptive Therapeutics has secured an exclusive licence from Washington University in St. Louis for a bioresorbable wireless electronic stimulation device designed for peripheral nerve repair. The deal grants Neuraptive rights to commercialize the technology, which represents a strategic licensing partnership in the neurology device space.
- 083MarketSource · Medical Design & Outsourcing
Ultrasound CDMO Vermon opens new plant and buys subsystem specialist
Vermon, a Tours, France-based ultrasound contract manufacturer, opened a new 30,000-square-foot TransducerWorks facility in Pennsylvania—four times larger than its predecessor and equipped with ISO 7 and ISO 8 cleanrooms and integrated machine shop—and acquired Modeleus, an OEM ultrasound subsystem specialist, to establish the Vermon Group platform.
- 084MarketSource · Medical Device Network
Edwards Lifesciences served $10m penalty over JC Medical acquisition violations
Edwards Lifesciences was ordered to pay a $10 million penalty after a court found the company violated antitrust law requirements in its 2024 acquisition of JC Medical. The FTC enforcement action followed a ruling that Edwards failed to comply with merger conditions.
- 085MarketSource · Medical Design & Outsourcing
Nitinol supplier Fort Wayne Metals sold
Axel Johnson Inc. has acquired Fort Wayne Metals and its parent company Fort Wayne Metals Research Products. The nitinol supplier, founded in 1970 and based in Fort Wayne, Indiana, will remain headquartered at its current location under new ownership. Financial terms were not disclosed.
- 086MarketSource · Medical Device Network
En Carta secures $6.18m to expand molecular testing solutions
En Carta Diagnostics closed €5 million ($6.18 million) in funding to expand its at-home molecular diagnostic solutions. The financing will support scaling of the company's testing platform for consumers and clinical applications.
- 087MarketSource · Medical Device Network
Virax Biolabs enters immune profiling product supply deal with Fosun
Virax Biolabs signed an exclusive commercial supply agreement with Fosun Diagnostics to distribute its ImmuneSelect immune profiling product line. The deal covers research-use-only applications of the immune profiling platform.
- 088MarketSource · Medical Device Network
Otsuka ICU Medical outlays $500m to expand US manufacturing footprint
Otsuka ICU Medical announced a $500 million investment to expand its US manufacturing capacity, including construction of a new facility and upgrades to its existing Austin, Texas site. The expansion reflects the company's commitment to domestic production and supply-chain resilience for its medical device portfolio.
- 089MarketSource · MedCity News
IKS Health Beefs Up Its Tech Stack with $557M Acquisition of TruBridge
IKS Health acquired TruBridge for $557 million, integrating the EHR and revenue-cycle management vendor into its AI-powered care platform. The deal marks IKS Health's third acquisition in 2026 and expands its footprint in rural-hospital IT services.
- 090MarketSource · Medical Device Network
GE HealthCare and Mayo Clinic partner for new theranostics research study
GE HealthCare and Mayo Clinic have announced a partnership to conduct a theranostics research study focused on radioligand therapy. The collaboration will evaluate how imaging and biomarker data can inform personalized treatment approaches using RLT, combining diagnostic insights with targeted therapeutic delivery.
- 091MarketSource · Medical Device Network
Leo Cancer Care raises $65m for upright radiotherapy platform
Leo Cancer Care raised $65 million in funding for its Marie radiotherapy platform, an upright positioning system paired with CT imaging for proton therapy delivery. The system received FDA clearance in July 2025. The funding supports commercialization of the platform, which addresses workflow and patient positioning in radiation oncology.
- 092MarketSource · Medical Device Network
Resmed sharpens sleep care focus with $490m software business sale
ResMed sold MatrixCare, its software business, to private-equity firm Frazier Healthcare Partners for $490 million, less than a decade after acquiring it for $750 million. The divestment reflects ResMed's strategic pivot to concentrate on its core sleep and respiratory care device portfolio.
- 093MarketSource · Medical Device Network
Ottobock expands neuro-orthotics portfolio with Fesia Technology acquisition
Ottobock acquired Fesia Technology to expand its neuro-orthotics offerings. The deal brings Fesia's portfolio of functional electrical stimulation (FES) products used in neurorehabilitation into Ottobock's product line, strengthening its position in the neurological rehabilitation device market.
- 094MarketSource · Medical Device Network
VB Spine to acquire rights to Augmedics’ CT-Fluoro technology
VB Spine has signed a definitive agreement to acquire exclusive rights to Augmedics' CT-Fluoro technology for spine surgery applications. CT-Fluoro combines computed tomography and fluoroscopy imaging to guide surgical procedures. The acquisition expands VB Spine's intraoperative imaging portfolio for spinal intervention.
- 095MarketSource · Medical Device Network
Alcon spends up to $200m to co-develop customisable cataract lenses with RxSight
Alcon and RxSight announced a co-development partnership valued at up to $200 million to create a tunable presbyopia-correcting intraocular lens (PCIOL) for cataract patients. The collaboration combines Alcon's surgical expertise with RxSight's light-adjustable lens technology to deliver customizable vision correction after implantation.
- 096MarketSource · Medical Device Network
Zydus and Apollo Hospitals sign MoU to launch MCD test in India
Zydus Lifesciences and Apollo Hospitals signed a memorandum of understanding to expand access to Shield, a multi-cancer detection test, across Apollo's hospital network in India. The partnership aims to broaden availability of the cancer screening diagnostic in the Indian market.
- 097MarketSource · Medical Device Network
Vivani strikes reverse-merger agreement with ClearOne for BCI business
Vivani Medical has entered a reverse-merger agreement with ClearOne, combining its brain-computer interface (BCI) business with ClearOne to create a publicly listed entity. Upon completion, the combined company will be renamed Cortigent Holdings and will trade on Nasdaq, providing Vivani's BCI technology with public market access.
- 098MarketSource · Medical Design & Outsourcing
Zimmer Biomet is adding hundreds of tech jobs in India
Zimmer Biomet plans to hire 500 technical professionals over three years at a new tech center in Bengaluru, India. Positions include software engineering, product design, R&D, quality, regulatory, and finance roles. The expansion reflects the orthopedic and spine device maker's strategy to build engineering and innovation capacity in lower-cost markets.
- 099MarketSource · Medical Device Network
Materna Medical raises $5m for women’s health device portfolio
Materna Medical closed a $5 million funding round to advance its women's health device portfolio. The capital will fund completion of a pivotal trial for its pelvic floor protection system during childbirth, alongside commercial expansion efforts.
- 100MarketSource · Medical Device Network
Zimmer Biomet to acquire iovera device from Pacira for $140m
Zimmer Biomet agreed to acquire Pacira BioSciences' iovera device, a drug-free pain management system, for up to $140 million. The transaction expands Zimmer Biomet's portfolio in the orthopedic and pain-relief device space.
- 101MarketSource · Medical Design & Outsourcing
High-precision stainless steel tubing supplier M&M International buys KC Tech
M&M International, a New Jersey-based supplier of high-precision stainless steel tubing for medical devices, has acquired KC Tech. M&M, founded in 1993, manufactures 304, 316-grade, and 17-7 stainless steel small-diameter tubing and operates manufacturing facilities in South Korea. The deal consolidates two suppliers serving the medical device sector.
- 102MarketSource · Medical Design & Outsourcing
Ex-Medtronic CEO Bill Hawkins joins Ketryx board
Bill Hawkins, retired Medtronic chair and CEO, has joined the board of Ketryx, a regulatory software platform for life sciences companies. Hawkins noted in a statement that medtech leaders are seeking ways to leverage AI to accelerate safe innovation, signaling growing industry interest in regulatory automation tools.
- 103MarketSource · Medical Device Network
Merck KGaA to buy Bio-Techne for $11.3bn in life science footprint expansion
Merck KGaA announced an $11.3 billion acquisition of Bio-Techne, a life sciences company, marking its largest deal since the 2015 purchase of Sigma-Aldrich for $17 billion. The transaction expands Merck's portfolio in research reagents, instruments, and related life science tools supplied to labs and medical institutions.
- 104MarketSource · Medical Device Network
Advanced Medical Solutions mulls £715m HB Fuller takeover bid
Advanced Medical Solutions is considering a £715 million acquisition of HB Fuller, which the companies say would expand the combined addressable market by $15 billion and add approximately $300 million in annual revenue. The deal represents a significant consolidation move within the medical equipment and supplies sector.
- 105MarketSource · Medical Device Network
Tissium wins €60m to bring sutureless nerve repair system to market
Tissium secured €60 million in financing to commercialize COAPTIUM CONNECT, a sutureless peripheral nerve repair surgical system, in the US market. The device represents a new approach to nerve repair that avoids traditional suturing techniques.
- 106MarketSource · MedCity News
Cadence Rakes In $100M to Automate Chronic Care at Scale
Cadence, an AI-powered chronic care platform, raised $100 million in Series C funding at a $1.23 billion valuation. The company's software monitors patients at home and adjusts medications in real time for heart failure, hypertension, and diabetes management through partnerships with health systems.
- 107MarketSource · MedCity News
Startup Raises $7M for Virtual-First Pediatric Therapy Model
Ladder Health closed a $7 million seed round led by Nina Capital to develop a virtual-first pediatric therapy platform. The funding round included participation from nine additional investors including Mairs & Power Venture Capital, Hatteras Venture Partners, and Create Health Ventures. The company is positioning itself in the digital health space for pediatric rehabilitation and therapy services.
- 108MarketSource · Medical Design & Outsourcing
VitalPath expands catheter manufacturing facility
VitalPath expanded its catheter manufacturing facility in Maplewood, Minnesota into a collaboration hub consolidating executive leadership, new product development, new product introduction, sustaining engineering, and manufacturing operations under one roof. The company said the consolidated approach aims to improve coordination across product development and manufacturing teams.
- 109MarketSource · Medical Device Network
ZEISS and Envision Health strike VR partnership to advance glaucoma care
ZEISS and Envision Health have formed a partnership to develop virtual-reality applications for glaucoma care. The collaboration combines ZEISS's optical and imaging expertise with Envision Health's digital-health platform to create tools aimed at improving diagnosis, monitoring, and patient management in glaucoma treatment.
- 110MarketSource · Medical Device Network
Zeal Specialty to support Chemo Mouthpiece device access in US
Chemomouthpiece has partnered with Zeal Specialty Pharmacy to expand US distribution of its Chemo Mouthpiece, an oral cooling device designed to reduce chemotherapy-induced oral mucositis. The partnership leverages Zeal's specialty pharmacy network to improve patient access to the device.
- 111MarketSource · Medical Device Network
Sonire Therapeutics awarded $13m from Japanese government-backed innovation agency
Sonire Therapeutics received a $13 million award from a Japanese government-backed innovation agency. The funding supports the company's development efforts, signaling continued investment in the vendor's technology platform and market expansion in Japan.
- 112MarketSource · Medical Design & Outsourcing
Cretex Medical expands with Holland Molds deal
Cretex Medical, a subsidiary of Cretex Cos., acquired select assets and capabilities from Holland Molds Inc. in Wadena, Minnesota, with the deal closing June 10. The purchase expands Cretex Medical's contract manufacturing and engineering service offerings through its Brooklyn Park-based Component & Device Technologies division.
- 113MarketSource · Medical Device Network
Italy’s WISE raises $34.8m in Series D to advance spinal cord stimulator development
WISE, an Italian medical device company, raised $34.8 million in Series D funding to advance development of its spinal cord stimulator (SCS) system. The device delivers targeted, directional stimulation via minimally invasive percutaneous implantation. The funding will support continued product development and commercialization efforts.
- 114MarketSource · Medical Device Network
Memphasys and Monash IVF sign national supply deal for Felix system
Memphasys and Monash IVF Group have signed a 12-month exclusive national supply agreement for the Felix automated sperm selection system. The deal grants Monash IVF exclusive rights to distribute the device across Australia.
- 115MarketSource · Medical Device Network
J&J outlays $1bn to strengthen Floridian contact lens manufacturing provision
Johnson & Johnson is investing $1 billion to strengthen its contact lens manufacturing capacity in Florida, specifically for its ACUVUE product line. The capital expenditure aims to enhance supply chain resilience and production capabilities for the contact lens portfolio.
- 116MarketSource · Medical Design & Outsourcing
MGS expands hybrid tooling for faster healthcare development
MGS, a healthcare contract development and manufacturing organization, expanded its hybrid tooling capabilities globally. The offering enables pharmaceutical, diagnostics, and medical device companies to validate product designs under production-like conditions before committing to full-scale manufacturing tooling, aimed at accelerating development timelines and reducing time-to-market.
- 117MarketSource · Medical Device Network
How Shockwave Medical plans to keep rivals at bay in burgeoning IVL sector
Shockwave Medical is strengthening its competitive position in the intravascular lithotripsy (IVL) market as rivals explore entry into the sector. The company is pursuing a strategy centered on continued innovation and clinical data generation to defend its market share against emerging competition.
- 118MarketSource · Medical Device Network
Podcast: How Shockwave Medical plans to keep rivals at bay in burgeoning IVL sector
Shockwave Medical, the pioneer in intravascular lithotripsy (IVL), is discussing competitive strategy as the sector gains traction and new entrants approach. IVL uses acoustic pulse technology to treat calcified vascular lesions, and Shockwave's early-mover advantage has driven strong adoption. The podcast explores how the company plans to maintain market position amid emerging competition in this growing interventional cardiology segment.
- 119MarketSource · Medical Design & Outsourcing
Gerresheimer expands Georgia plant and makes automation upgrades
Gerresheimer, a German medical device CDMO, has expanded its Peachtree City, Georgia manufacturing facility and installed two automated storage and retrieval systems (AS/RS) to boost production and logistics capacity. The plant manufactures inhalers, infusion components, microinjectors, microbiological test cards, and autoinjectors.
- 120MarketSource · Medical Device Network
GT Medical Technologies raises $100m for brain tumour therapy advance
GT Medical Technologies secured $100 million in funding to advance its GammaTile brachytherapy system for brain tumor treatment. The company presented final Phase III clinical data comparing GammaTile against standard of care at the ASCO annual meeting, supporting the device's therapeutic profile and market positioning.